Current status of distal embolization in percutaneous coronary intervention: mechanical and pharmacological strategies

Bibliography Papers of special note have been highlighted as: ▪ of interest ▪▪ of considerable interest

References

• 1  Keeley EC, Boura JA, Grines CL: Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet361(9351),13–20 (2003).
  MedlineGoogle Scholar
• 2  Henriques JP, Zijlstra F: Frequency and sequelae of ST elevation acute myocardial infarction caused by spontaneous distal embolization from unstable coronary lesions. Am. J. Cardiol.91(6),708–711 (2003).▪▪ Patients with distal embolization on the angiogram before primary angioplasty constitute a distinct pathophysiologic subset of patients.
  MedlineGoogle Scholar
• 3  Rezkalla SH, Kloner RA: No-reflow phenomenon. Circulation105(5),656–662 (2002).
  MedlineGoogle Scholar
• 4  Kloner RA, Rude RE, Carlson N et al.: Ultrastructural evidence of microvascular damage and myocardial cell injury after coronary artery occlusion: which comes first? Circulation62(5),945–952 (1980).
  Medline CASGoogle Scholar
• 5  van Gaal WJ, Banning AP: Percutaneous coronary intervention and the no-reflow phenomenon. Expert. Rev. Cardiovasc. Ther.5(4),715–731 (2007).▪▪ Summary of the ‘no-reflow’ phenomenon in percutaneous coronary intervention (PCI).
  MedlineGoogle Scholar
• 6  Ito H: No-reflow phenomenon and prognosis in patients with acute myocardial infarction. Nat. Clin. Pract. Cardiovasc. Med.3(9),499–506 (2006).
  MedlineGoogle Scholar
• 7  Kotani J, Nanto S, Mintz GS et al.: Plaque gruel of atheromatous coronary lesion may contribute to the no-reflow phenomenon in patients with acute coronary syndrome. Circulation106(13),1672–1677 (2002).
  MedlineGoogle Scholar
• 8  Henriques JP, Zijlstra F, Ottervanger JP et al.: Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction. Eur. Heart J.23(14),1112–1117 (2002).▪ First study to report the incidence and clinical significance of angiographically visualized distal embolization in patients with acute myocardial infarction (MI) treated with primary angioplasty.
  Medline CASGoogle Scholar
• 9  Fokkema ML, Vlaar PJ, Svilaas T et al.: Incidence and clinical consequences of distal embolization on the coronary angiogram after percutaneous coronary intervention for ST-elevation myocardial infarction. Eur. Heart J.30(8),908–915 (2009).▪▪ Demonstrates that angiographically documented distal embolizations have an incidence of 6.3% in an unselected contemporary population with acute MI. Early administration of aspirin, heparin and clopidogrel before intervention may have contributed to the low incidence of distal embolization compared with previous reports.
  MedlineGoogle Scholar
• 10  Napodano M, Ramondo A, Tarantini G et al.: Predictors and time-related impact of distal embolization during primary angioplasty. Eur. Heart J.30(3),305–313 (2009).
  MedlineGoogle Scholar
• 11  Sianos G, Papafaklis MI, Daemen J et al.: Angiographic stent thrombosis after routine use of drug-eluting stents in ST-segment elevation myocardial infarction: the importance of thrombus burden. J. Am. Coll. Cardiol.50(7),573–583 (2007).
  Medline CASGoogle Scholar
• 12  Hiscock M, Oqueli E, Dick R: Percutaneous saphenous vein graft intervention – a review. Heart Lung Circ.16(Suppl. 3),S51–S55 (2007).▪▪ Summary of saphenous vein graft (SVG) intervention.
  MedlineGoogle Scholar
• 13  Webb JG, Carere RG, Virmani R et al.: Retrieval and analysis of particulate debris after saphenous vein graft intervention. J. Am. Coll. Cardiol.34(2),468–475 (1999).
  Medline CASGoogle Scholar
• 14  Coolong A, Baim DS, Kuntz RE et al.: Saphenous vein graft stenting and major adverse cardiac events: a predictive model derived from a pooled analysis of 3958 patients. Circulation117(6),790–797 (2008).▪▪ Shows that predictors of 30-day major adverse cardiac events in SVG PCI are angiographic estimates of plaque volume and SVG degeneration.
  MedlineGoogle Scholar
• 15  Okamura A, Ito H, Iwakura K et al.: Detection of embolic particles with the Doppler guide wire during coronary intervention in patients with acute myocardial infarction: efficacy of distal protection device. J. Am. Coll. Cardiol.45(2),212–215 (2005).▪▪ Demonstrates for the first time that an intracoronary Doppler guidewire can detect emboli as high-intensity transient signal associated with PCI and the use of a distal protection device can effectively reduce the number of embolic particles.
  MedlineGoogle Scholar
• 16  Buller CE, Fu Y, Mahaffey KW et al.: ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial. Circulation118(13),1335–1346 (2008).▪▪ Shows the power of the 12-lead ECG performed early after primary PCI for predicting death, heart failure or shock up to 90 days after STEMI.
  MedlineGoogle Scholar
• 17  McLaughlin MG, Stone GW, Aymong E et al.: Prognostic utility of comparative methods for assessment of ST-segment resolution after primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. J. Am. Coll. Cardiol.44(6),1215–1223 (2004).
  MedlineGoogle Scholar
• 18  Moons KG, Klootwijk P, Meij SH et al.: Continuous ST-segment monitoring associated with infarct size and left ventricular function in the GUSTO-I trial. Am. Heart J.138(3 Pt 1),525–532 (1999).
  Medline CASGoogle Scholar
• 19  van ‘t Hof AW, Liem A, de Boer MJ, Zijlstra F: Clinical value of 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction. Zwolle Myocardial infarction Study Group. Lancet350(9078),615–619 (1997).
  MedlineGoogle Scholar
• 20  Judd RM, Lugo-Olivieri CH, Arai M et al.: Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-day-old reperfused canine infarcts. Circulation92(7),1902–1910 (1995).
  Medline CASGoogle Scholar
• 21  Hirsch A, Nijveldt R, Haeck JD et al.: Relation between the assessment of microvascular injury by cardiovascular magnetic resonance and coronary Doppler flow velocity measurements in patients with acute anterior wall myocardial infarction. J. Am. Coll. Cardiol.51(23),2230–2238 (2008).
  MedlineGoogle Scholar
• 22  Nijveldt R, Beek AM, Hirsch A et al.: Functional recovery after acute myocardial infarction: comparison between angiography, electrocardiography, and cardiovascular magnetic resonance measures of microvascular injury. J. Am. Coll. Cardiol.52(3),181–189 (2008).
  MedlineGoogle Scholar
• 23  Silber S, Albertsson P, Aviles FF et al.: Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur. Heart J.26(8),804–847 (2005).
  MedlineGoogle Scholar
• 24  Smith SC Jr, Feldman TE, Hirshfeld JW Jr et al.: ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention – summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). Circulation113(1),156–175 (2006).
  MedlineGoogle Scholar
• 25  Gibson CM, Zorkun C, Kunadian V: Intracoronary administration of abciximab in ST-elevation myocardial infarction. Circulation118(1),6–8 (2008).
  MedlineGoogle Scholar
• 26  Lee KW, Norell MS: Management of ‘no-reflow’ complicating reperfusion therapy. Acute. Card Care10(1),5–14 (2008).
  MedlineGoogle Scholar
• 27  Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT-4 PCI) investigators: Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial. Lancet367(9510),569–578 (2006).
  MedlineGoogle Scholar
• 28  Ellis SG, Tendera M, de Belder MA et al.: Facilitated PCI in patients with ST-elevation myocardial infarction. N. Engl. J. Med.358(21),2205–2217 (2008).
  Medline CASGoogle Scholar
• 29  Mehilli J, Kastrati A, Schulz S et al.: Abciximab in patients with acute ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention after clopidogrel loading: a randomized double-blind trial. Circulation119(14),1933–1940 (2009).▪▪ Demonstrates that upstream of abciximab is not associated with a reduction in infarct size in patients presenting with acute MI within 24 h of symptom onset and receiving 600 mg of clopidogrel.
  Medline CASGoogle Scholar
• 30  Matsuo A, Inoue N, Suzuki K et al.: Limitations of using a GuardWire temporary occlusion and aspiration system in patients with acute myocardial infarction: multicenter investigation of coronary artery protection with a distal occlusion device in acute myocardial infarction (MICADO). J. Invasive Cardiol.19(3),132–138 (2007).
  MedlineGoogle Scholar
• 31  Muramatsu T, Kozuma K, Tsukahara R et al.: Comparison of myocardial perfusion by distal protection before and after primary stenting for acute myocardial infarction: Angiographic and clinical results of a randomized controlled trial. Catheter. Cardiovasc. Interv.70(5),677–682 (2007).
  MedlineGoogle Scholar
• 32  Stone GW, Webb J, Cox DA et al.: Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: a randomized controlled trial. JAMA293(9),1063–1072 (2005).▪ Shows that the use of a distal embolic protection device in primary PCI did not result in improved microvascular flow, greater reperfusion success, reduced infarct size, or enhanced event-free survival.
  Medline CASGoogle Scholar
• 33  Tahk SJ, Choi BJ, Choi SY et al.: Distal protection device protects microvascular integrity during primary percutaneous intervention in acute myocardial infarction: a prospective, randomized, multicenter trial. Int. J. Cardiol.123(2),162–168 (2007).
  MedlineGoogle Scholar
• 34  Gick M, Jander N, Bestehorn HP et al.: Randomized evaluation of the effects of filter-based distal protection on myocardial perfusion and infarct size after primary percutaneous catheter intervention in myocardial infarction with and without ST-segment elevation. Circulation112(10),1462–1469 (2005).
  MedlineGoogle Scholar
• 35  Kelbaek H, Terkelsen CJ, Helqvist S et al.: Randomized comparison of distal protection versus conventional treatment in primary percutaneous coronary intervention: the drug elution and distal protection in ST-elevation myocardial infarction (DEDICATION) trial. J. Am. Coll. Cardiol.51(9),899–905 (2008).
  MedlineGoogle Scholar
• 36  Koch KT, Haeck JD, van der Schaaf RJ et al.: Proximal embolic protection with aspiration in percutaneous corononary intervention using the proxistrade mark device. Rev. Cardiovasc. Med.8(3),160–166 (2007).▪▪ Demontrates the safety and feasibility of combined proximal embolic protection and thrombus aspiration using the Proxis system in primary PCI for acute MI.
  MedlineGoogle Scholar
• 37  Haeck JD, Koch KT, Bilodeau L et al.: Randomized comparison of primary percutaneous coronary intervention with combined proximal embolic protection and thrombus aspiration and primary percutaneous coronary intervention alone in ST-segment elevation myocardial infarction. Presented at the American College of Cardiology and i2 Summit 2009, Orlando. J. Am. Coll. Cardiol. Suppl.A-28,2612–2619 (2009).
  Google Scholar
• 38  Ali A, Cox D, Dib N et al.: Rheolytic thrombectomy with percutaneous coronary intervention for infarct size reduction in acute myocardial infarction: 30-day results from a multicenter randomized study. J. Am. Coll. Cardiol.48(2),244–252 (2006).
  MedlineGoogle Scholar
• 39  Antoniucci D, Valenti R, Migliorini A et al.: Comparison of rheolytic thrombectomy before direct infarct artery stenting versus direct stenting alone in patients undergoing percutaneous coronary intervention for acute myocardial infarction. Am. J. Cardiol.93(8),1033–1035 (2004).
  MedlineGoogle Scholar
• 40  Beran G, Lang I, Schreiber W et al.: Intracoronary thrombectomy with the X-sizer catheter system improves epicardial flow and accelerates ST-segment resolution in patients with acute coronary syndrome: a prospective, randomized, controlled study. Circulation105(20),2355–2360 (2002).
  MedlineGoogle Scholar
• 41  Lefevre T, Garcia E, Reimers B et al.: X-sizer for thrombectomy in acute myocardial infarction improves ST-segment resolution: results of the X-sizer in AMI for negligible embolization and optimal ST resolution (X AMINE ST) trial. J. Am. Coll. Cardiol.46(2),246–252 (2005).
  MedlineGoogle Scholar
• 42  Napodano M, Pasquetto G, Sacca S et al.: Intracoronary thrombectomy improves myocardial reperfusion in patients undergoing direct angioplasty for acute myocardial infarction. J. Am. Coll. Cardiol.42(8),1395–1402 (2003).
  MedlineGoogle Scholar
• 43  De Carlo M, Wood DA, Webb JG et al.: Adjunctive use of the Rinspiration system for fluidic thrombectomy during primary angioplasty: the Rinspiration international registry. Catheter. Cardiovasc. Interv.72(2),196–203 (2008).
  MedlineGoogle Scholar
• 44  Burzotta F, Trani C, Romagnoli E et al.: Manual thrombus-aspiration improves myocardial reperfusion: the randomized evaluation of the effect of mechanical reduction of distal embolization by thrombus-aspiration in primary and rescue angioplasty (REMEDIA) trial. J. Am. Coll. Cardiol.46(2),371–376 (2005).
  MedlineGoogle Scholar
• 45  De Luca L, Sardella G, Davidson CJ et al.: Impact of intracoronary aspiration thrombectomy during primary angioplasty on left ventricular remodelling in patients with anterior ST elevation myocardial infarction. Heart92(7),951–957 (2006).
  Medline CASGoogle Scholar
• 46  Silva-Orrego P, Colombo P, Bigi R et al.: Thrombus aspiration before primary angioplasty improves myocardial reperfusion in acute myocardial infarction: the DEAR-MI (Dethrombosis to Enhance Acute Reperfusion in Myocardial Infarction) study. J. Am. Coll. Cardiol.48(8),1552–1559 (2006).
  MedlineGoogle Scholar
• 47  Kaltoft A, Bottcher M, Nielsen SS et al.: Routine thrombectomy in percutaneous coronary intervention for acute ST-segment-elevation myocardial infarction: a randomized, controlled trial. Circulation114(1),40–47 (2006).▪ Demonstrates that thrombectomy performed as routine therapy in primary PCI for STEMI does not increase myocardial salvage. The study suggests a possible deleterious effect of thrombectomy, resulting in an increased final infarct size, and does not support the use of thrombectomy in unselected primary PCI patients.
  MedlineGoogle Scholar
• 48  Ikari Y, Sakurada M, Kozuma K et al.: Upfront thrombus aspiration in primary coronary intervention for patients with ST-segment elevation acute myocardial infarction: report of the VAMPIRE (VAcuuM asPIration thrombus REmoval) trial. JACC Cardiovasc. Interv.1(4),424–431 (2008).
  MedlineGoogle Scholar
• 49  Svilaas T, Vlaar PJ, van der Horst, I et al.: Thrombus aspiration during primary percutaneous coronary intervention. N. Engl. J. Med.358(6),557–567 (2008).
  Medline CASGoogle Scholar
• 50  Vlaar PJ, Svilaas T, van der Horst I et al.: Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS): a 1-year follow-up study. Lancet371(9628),1915–1920 (2008).▪ Shows that thrombus aspiration before stenting of the infarct-related artery results in improved 1-year clinical outcome after PCI for STEMI.
  MedlineGoogle Scholar
• 51  Sardella G, Mancone M, Bucciarelli-Ducci C et al.: Thrombus aspiration during primary percutaneous coronary intervention improves myocardial reperfusion and reduces infarct size: the EXPIRA (thrombectomy with export catheter in infarct-related artery during primary percutaneous coronary intervention) prospective, randomized trial. J. Am. Coll. Cardiol.53(4),309–315 (2009).▪▪ Shows that thrombectomy prevents thrombus embolization and preserves microvascular integrity reducing infarct size, and it therefore represents an useful adjunctive therapy in primary PCI.
  MedlineGoogle Scholar
• 52  De Luca G, Dudek D, Sardella G, Marino P, Chevalier B, Zijlstra F: Adjunctive manual thrombectomy improves myocardial perfusion and mortality in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis of randomized trials. Eur. Heart J.29(24),3002–3010 (2008).
  MedlineGoogle Scholar
• 53  De Luca G, Suryapranata H, Stone GW et al.: Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials. JAMA293(14),1759–1765 (2005).
  Medline CASGoogle Scholar
• 54  Montalescot G, Antoniucci D, Kastrati A et al.: Abciximab in primary coronary stenting of ST-elevation myocardial infarction: a European meta-analysis on individual patients’ data with long-term follow-up. Eur. Heart J.28(4),443–449 (2007).
  Medline CASGoogle Scholar
• 55  De Luca G, Ucci G, Cassetti E, Marino P: Benefits from small molecule administration as compared with abciximab among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-analysis. J. Am. Coll. Cardiol.53(18),1668–1673 (2009).
  Medline CASGoogle Scholar
• 56  Thiele H, Schindler K, Friedenberger J et al.: Intracoronary compared with intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the randomized Leipzig immediate percutaneous coronary intervention abciximab IV versus IC in ST-elevation myocardial infarction trial. Circulation118(1),49–57 (2008).▪▪ Demonstrates that intracoronary bolus administration of abciximab in primary PCI is superior to standard intravenous treatment with respect to infarct size, extent of microvascular obstruction and perfusion.
  Medline CASGoogle Scholar
• 57  Sezer M, Oflaz H, Goren T et al.: Intracoronary streptokinase after primary percutaneous coronary intervention. N. Engl. J. Med.356(18),1823–1834 (2007).
  Medline CASGoogle Scholar
• 58  Hong MK, Mehran R, Dangas G et al.: Creatine kinase-MB enzyme elevation following successful saphenous vein graft intervention is associated with late mortality. Circulation100(24),2400–2405 (1999).
  Medline CASGoogle Scholar
• 59  Baim DS, Wahr D, George B et al.: Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation105(11),1285–1290 (2002).▪ Demonstrates that the use of distal protection device during stenting of SVGs was associated with a highly significant reduction in major adverse events compared with stenting over a conventional angioplasty guidewire. This demonstrates the importance of distal embolization in causing major adverse cardiac events and the value of embolic protection devices in preventing such complications.
  MedlineGoogle Scholar
• 60  Stone GW, Rogers C, Hermiller J et al.: Randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aorto-coronary bypass grafts. Circulation108(5),548–553 (2003).
  MedlineGoogle Scholar
• 61  Carrozza JP Jr, Mumma M, Breall JA, Fernandez A, Heyman E, Metzger C: Randomized evaluation of the TriActiv balloon-protection flush and extraction system for the treatment of saphenous vein graft disease. J. Am. Coll. Cardiol.46(9),1677–1683 (2005).
  MedlineGoogle Scholar
• 62  Mauri L, Cox D, Hermiller J et al.: The PROXIMAL trial: proximal protection during saphenous vein graft intervention using the Proxis Embolic Protection System: a randomized, prospective, multicenter clinical trial. J. Am. Coll. Cardiol.50(15),1442–1449 (2007).▪ Demonstration of the safety and efficacy of the Proxis system in SVG interventions.
  MedlineGoogle Scholar
• 63  Kereiakes DJ, Turco MA, Breall J et al.: A novel filter-based distal embolic protection device for percutaneous intervention of saphenous vein graft lesions: results of the AMEthyst randomized controlled trial. JACC Cardiovasc. Interv.1(3),248–257 (2008).
  MedlineGoogle Scholar
• 64  Roffi M, Mukherjee D, Chew DP et al.: Lack of benefit from intravenous platelet glycoprotein IIb/IIIa receptor inhibition as adjunctive treatment for percutaneous interventions of aortocoronary bypass grafts: a pooled analysis of five randomized clinical trials. Circulation106(24),3063–3067 (2002).
  MedlineGoogle Scholar
• 65  Topol EJ, Yadav JS: Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation101(5),570–580 (2000).▪▪ Summary of the role of embolization in atherosclerotic vascular disease.
  Medline CASGoogle Scholar
• 66  Michaels AD, Appleby M, Otten MH et al.: Pretreatment with intragraft verapamil prior to percutaneous coronary intervention of saphenous vein graft lesions: results of the randomized, controlled vasodilator prevention on no-reflow (VAPOR) trial. J. Invasive Cardiol.14(6),299–302 (2002).
  MedlineGoogle Scholar
• 67  Stone GW, Witzenbichler B, Guagliumi G et al.: Bivalirudin during primary PCI in acute myocardial infarction. N. Engl. J. Med.358(21),2218–2230 (2008).
  Medline CASGoogle Scholar
• 68  Wiviott SD, Braunwald E, McCabe CH et al.: Prasugrel versus clopidogrel in patients with acute coronary syndromes. N. Engl. J. Med.357(20),2001–2015 (2007).
  Medline CASGoogle Scholar
• 69  Cura FA, Escudero AG, Berrocal D et al.: Protection of Distal Embolization in High-Risk Patients with Acute ST-Segment Elevation Myocardial Infarction (PREMIAR). Am. J. Cardiol.99(3),357–363 (2007).
  MedlineGoogle Scholar
• 70  Dudek D, Mielecki W, Legutko J et al.: Percutaneous thrombectomy with the RESCUE system in acute myocardial infarction. Kardiol. Pol.61(12),523–533 (2004).
  MedlineGoogle Scholar
• 71  De Luca L, Sardella G, Davidson CJ et al.: Impact of intracoronary aspiration thrombectomy during primary angioplasty on left ventricular remodelling in patients with anterior ST elevation myocardial infarction. Heart92(7),951–957 (2006).
  Medline CASGoogle Scholar
• 72  Chevalier B, Gilard M, Lang I et al.: Systematic primary aspiration in acute myocardial percutaneous intervention: a multicentre randomised controlled trial of the export aspiration catheter. EuroIntervention4(2),222–228 (2008).
  MedlineGoogle Scholar